VBWG
Slides

ERICA: Efficacy of Ranolazine In Chronic Angina



ERICA

Download VBWG06_ERICA.ppt (11 slides - 0.6MB)

ERICA Background and hypothesis ERICA: Study design ERICA: Concomitant medications ERICA: Ranolazine reduces angina frequency and nitrate consumption ERICA: Consistent treatment effect regardless of gender, age, and concomitant long-acting nitrates ERICA subgroup analyses: Frequency of angina ERICA: No significant effect on heart rate or BP ERICA: Safety and tolerability ERICA: Summary Implications


AnginaERICARanolazine

Related at vwbg.org

Results from CRUSADE: Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines

CRUSADE investigated the association between dosing levels of antithrombotic agents and bleeding, in-hospital mortality, and length of stay in patients with NSTE ACS.

RITA 3: Benefit of early invasive strategy in moderate-risk unstable angina patients

Final results of RITA 3 (Randomized Intervention Trial of unstable Angina) confirm that an interventional strategy results in a statistically significant reduction in the combined outcome of death, nonfatal myocardial infarction (MI), or refractory angina.
More related